Depression, Anxiety and Sleep in Parkinson's Disease
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Parkinson's Disease. Basic parameters: from 50 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Assessment of Depression , Anxiety and Sleep Disorders in Patients With Idiopathic Parkinson's Disease
Overview
This study aims to assess the prevalence and severity of depression, anxiety, and sleep disorders among patients with idiopathic Parkinson's disease. The study will evaluate the relationship between neuropsychiatric symptoms and disease characteristics in order to improve early recognition and patient quality of life.
Primary outcome measures
- Assessment of Depression Severity in Patients with idiopathic Parkinson's Disease [Time frame: Baseline assessment during study enrollment.]
- Assessment of Anxiety Severity in Patients with idiopathic Parkinson's Disease [Time frame: Baseline]
- Assessment of Sleep Disturbance in Patients with idiopathic Parkinson's Disease [Time frame: Baseline]
Eligibility criteria
A-Inclusion Criteria:
- Patients diagnosed with idiopathic Parkinson's disease according to the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's Disease (Postuma et al., 2015).
- Age ≥ 50 years.
- Ability to understand and respond to questionnaires and rating scales.
- Ability and willingness to provide informed consent.
B-Exclusion Criteria:
- Patients with atypical parkinsonism.
- Patients with a history of other major neurological disorders (e.g., stroke, Alzheimer's disease, multiple sclerosis).
- Patients with severe cognitive impairment or dementia that prevents reliable completion of rating scales.
- Patients with a current diagnosis of severe psychiatric disorders unrelated to 5-Parkinson's disease (e.g., schizophrenia, bipolar disorder).
6-Patients with unstable medical conditions. 7-Patients unable or unwilling to provide informed consent.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07622303 · Soh-Med-26-5-4MS